Bone formation in algae-derived and synthetic calcium phosphates with or without poloxamer

Journal of Craniofacial Surgery

Volumn 24, Issue 2, 2013, Pages 354-359

  Zhou, Aileen Jing Jing ^a   Clokie, Cameron Malcolm Lang ^a   Peel, Sean Alexander Fitzgerald ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biphasic calcium phosphate; Bone regeneration; Hydroxyapatite; Poloxamer; Rabbit calvarial defects

Indexed keywords

CALCIUM PHOSPHATE; POLOXAMER;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; MALE; MICRO-COMPUTED TOMOGRAPHY; RABBIT; RADIOGRAPHY; RED ALGA; SKULL; WOUND HEALING;

ANIMALS; CALCIUM PHOSPHATES; MALE; OSTEOGENESIS; POLOXAMER; RABBITS; RHODOPHYTA; SKULL; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 84878479361     PISSN: 10492275     EISSN: 15363732     Source Type: Journal    
DOI: 10.1097/SCS.0b013e318267ba3f     Document Type: Article

References (18)

1. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3: 192-195
2. Brydone AS, Meek D, Maclaine S. Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering. Proc Inst Mech Eng H 2010; 224: 1329-1343
3. Tadic D, Epple M. A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone. Biomaterials 2004; 25: 987-994
4. Burg KJ, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials 2000; 21: 2347-2359
5. Lu J, Descamps M, Dejou J, et al. The biodegradation mechanism of calcium phosphate biomaterials in bone. J Biomed Mater Res 2002; 63: 408-412
6. Piattelli A, Scarano A, Mangano C. Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. Biomaterials 1996; 17: 1767-1770
7. Spassova E, Gintenreiter S, Halwax E, et al. Chemistry, ultrastructure and porosity of monophasic and biphasic bone forming materials derived from marine algae. Mat-Wiss U Werkstofftech 2007; 38: 1-8
8. Ewers RSC, Gossweiner S, Spassova E, et al. AligiPore: carrier material for bone morphogenetic protein. J Cranio Max Fac Surg 1998; 26(suppl 1); 46
9. Dumortier G, Grossiord JL, Agnely F, et al. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006; 23: 2709-2728
10. Escobar-Chavez JJ, Lopez-Cervantes M, Naik A, et al. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 2006; 9: 339-358
11. Park H, Park K. Biocompatibility issues of implantable drug delivery systems. Pharm Res 1996; 13: 1770-1776
12. Clokie CM, Moghadam H, Jackson MT, et al. Closure of critical sized defects with allogenic and alloplastic bone substitutes. J Craniofac Surg 2002; 13: 111-121
13. Zhou AJ, Peel SA, Clokie CM. An evaluation of hydroxyapatite and biphasic calcium phosphate in combination with Pluronic F127 and BMP on bone repair. J Craniofac Surg 2007; 18: 1264-1275
14. Kruyt MC, Wilson CE, de Bruijn JD, et al. The effect of cell-based bone tissue engineering in a goat transverse process model. Biomaterials 2006; 27: 5099-5106
15. Yuan H, van Blitterswijk CA, de Groot K, et al. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. Tissue Eng 2006; 12: 1607-1615
16. Yuan H, van Blitterswijk CA, de Groot K, et al. A comparison of bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) implanted in muscle and bone of dogs at different time periods. J Biomed Mater Res A 2006; 78: 139-147
17. Wang MY, Armstrong JK, Fisher TC, et al. A new, pluronic-based, bone hemostatic agent that does not impair osteogenesis. Neurosurgery 2001; 49: 962-967
18. Fowler EB, Cuenin MF, Hokett SD, et al. Evaluation of pluronic polyols as carriers for grafting materials: study in rat calvaria defects. J Periodontol 2002; 73: 191-197